LEOCLANLtd Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 3/6
LEOCLANLtd's earnings have been declining at an average annual rate of -16.6%, while the Healthcare industry saw earnings growing at 6.4% annually. Revenues have been declining at an average rate of 2.2% per year. LEOCLANLtd's return on equity is 4.9%, and it has net margins of 1%.
Key information
-16.6%
Earnings growth rate
-18.2%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | -2.2% |
| Return on equity | 4.9% |
| Net Margin | 1.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How LEOCLANLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 25,671 | 266 | 2,454 | 0 |
| 31 Mar 24 | 27,186 | 348 | 2,443 | 0 |
| 31 Dec 23 | 27,109 | 375 | 2,413 | 0 |
| 30 Sep 23 | 26,632 | 271 | 2,378 | 0 |
| 30 Jun 23 | 21,246 | 7 | 2,411 | 0 |
| 31 Mar 23 | 22,673 | 35 | 2,407 | 0 |
| 31 Dec 22 | 24,025 | 25 | 2,429 | 0 |
| 30 Sep 22 | 29,767 | 437 | 2,404 | 0 |
| 30 Jun 22 | 30,070 | 475 | 2,343 | 0 |
| 31 Mar 22 | 28,225 | 347 | 2,273 | 0 |
| 31 Dec 21 | 29,054 | 513 | 2,179 | 0 |
| 30 Sep 21 | 26,347 | 390 | 2,156 | 0 |
| 30 Jun 21 | 27,744 | 664 | 2,072 | 0 |
| 31 Mar 21 | 26,534 | 664 | 2,037 | 0 |
| 31 Dec 20 | 23,759 | 379 | 2,054 | 0 |
| 30 Sep 20 | 21,996 | 120 | 2,051 | 0 |
| 30 Jun 20 | 23,585 | 13 | 2,123 | 0 |
| 30 Sep 19 | 36,109 | 732 | 2,157 | 0 |
| 30 Sep 18 | 25,715 | 357 | 2,043 | 0 |
| 30 Sep 17 | 19,060 | 242 | 1,924 | 0 |
Quality Earnings: 7681 has a large one-off gain of ¥92.0M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 7681's current net profit margins (1%) are higher than last year (0.03%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7681's earnings have declined by 16.6% per year over the past 5 years.
Accelerating Growth: 7681's earnings growth over the past year (3700%) exceeds its 5-year average (-16.6% per year).
Earnings vs Industry: 7681 earnings growth over the past year (3700%) exceeded the Healthcare industry 10.6%.
Return on Equity
High ROE: 7681's Return on Equity (4.9%) is considered low.